TRAVOPROST Mepha gtt opht 40 mcg/ml 3 fl 2.5 ml

7680662400023 CH-66240 S01EE04 11.09.0.

Active substances:

No images available

Details

Product number
6624001
CPT
-
Packaging group
3 x 2,5
Unit
ml
Composition
travoprostum 40 µg, benzalkonii chloridi solutio 150.51 µg, macrogolglyceroli hydroxystearas, trometamolum, dinatrii edetas, acidum boricum, mannitolum, natrii hydroxidum ad pH, aqua purificata q.s. ad solutionem pro 1 ml.

Articles (1)

Travoprost-Mepha, Augentropfen
Augentropfen
3 x 2,5
View

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
travoprostum
40.0 UG Substance Wirkstoff (Principe actif)
benzalkonii chloridi solutio
150.51 UG Substance HBESI
macrogolglyceroli hydroxystearas
- Substance HNIDK
trometamolum
- Substance HNIDK
dinatrii edetas
- Substance HNIDK
acidum boricum
- Substance HNIDK
mannitolum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua purificata
- Substance HNIDK

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66240
Drug name
Travoprost-Mepha, Augentropfen
Galenic form
AUGT
ATC Code
S01EE04
Authorization status
Z
Dispensation category
B
First authorization
15/09/2016
Authorization expiration date
01/09/2026
IT number
11.09.0.
Domain
Human medicine
Field of application
Glaukom

Packaging details

Description (FR)
TRAVOPROST Mepha gtt opht 40 mcg/ml 3 fl 2.5 ml
Description (DE)
TRAVOPROST Mepha Gtt Opht 40 mcg/ml 3 Fl 2.5 ml
Market launch
15/09/2016
Market withdrawal
01/09/2026
Narcotic (BTM)
No

Available generics

Travo-Vision, Augentropfen
CHF 17.90
View
Travo-Vision, Augentropfen
CHF 41.15
View
Travo-Vision SDU, Augentropfen im Einzeldosisbehältnis
CHF 17.90
View
Travo-Vision SDU, Augentropfen im Einzeldosisbehältnis
CHF 41.15
View

Other packaging sizes

TRAVOPROST Mepha gtt opht 40 mcg/ml fl 2.5 ml
2,5 ML
View
Buy us a coffee Explore the data